1-4 of 4
A Koenig
Close
Sort by
Journal Articles

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Clinical Trials & Observations
Han W. Tun, Patrick B. Johnston, Lisa M. DeAngelis, Pamela J. Atherton, Levi D. Pederson, Patricia A. Koenig, Craig B. Reeder, Antonio M. Padula Omuro, David Schiff, Brian O’Neill, Jose Pulido, Kurt A. Jaeckle, Christian Grommes, Thomas E. Witzig
Journal: Blood
Blood (2018) 132 (21): 2240–2248.
https://doi.org/10.1182/blood-2018-02-835496
Published: 2018
Includes: Supplemental data
Journal Articles

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

Manuel Schmidt, Javier de Christobal, Nicole Hagner, Astrid Sander, Alberto Marco, Sven A. Koenig-Merediz, Burghardt Wittig
Journal: Blood
Blood (2005) 106 (11): 3915.
https://doi.org/10.1182/blood.V106.11.3915.3915
Published: 2005
Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. Koenig-Merediz, Burghardt Wittig
Journal: Blood
Blood (2005) 106 (11): 5527.
https://doi.org/10.1182/blood.V106.11.5527.5527
Published: 2005
Journal Articles

Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation

A Koenig, E Yakisan, M Reuter, M Huang, KW Sykora, S Corbacioglu, K Welte
Journal: Blood
Blood (1994) 83 (10): 2836–2843.
https://doi.org/10.1182/blood.V83.10.2836.2836
Published: 1994